5qt2
From Proteopedia
(Difference between revisions)
m (Protected "5qt2" [edit=sysop:move=sysop]) |
|||
(One intermediate revision not shown.) | |||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==PanDDA analysis group deposition -- Partial occupancy interpretation of PanDDA event map: SETDB1 in complex with FMOPL000074a== | |
- | + | <StructureSection load='5qt2' size='340' side='right'caption='[[5qt2]], [[Resolution|resolution]] 1.59Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[5qt2]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5QT2 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5QT2 FirstGlance]. <br> | |
- | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.59Å</td></tr> | |
- | [[Category: | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=AW7:2-[4-(1~{H}-pyrazol-3-yl)phenoxy]pyrimidine'>AW7</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=UNX:UNKNOWN+ATOM+OR+ION'>UNX</scene></td></tr> |
- | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5qt2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5qt2 OCA], [https://pdbe.org/5qt2 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5qt2 RCSB], [https://www.ebi.ac.uk/pdbsum/5qt2 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5qt2 ProSAT]</span></td></tr> |
- | [[Category: | + | </table> |
- | [[Category: | + | == Function == |
- | [[Category: | + | [https://www.uniprot.org/uniprot/SETB1_HUMAN SETB1_HUMAN] Histone methyltransferase that specifically trimethylates 'Lys-9' of histone H3. H3 'Lys-9' trimethylation represents a specific tag for epigenetic transcriptional repression by recruiting HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. Mainly functions in euchromatin regions, thereby playing a central role in the silencing of euchromatic genes. H3 'Lys-9' trimethylation is coordinated with DNA methylation. Probably forms a complex with MBD1 and ATF7IP that represses transcription and couples DNA methylation and histone 'Lys-9' trimethylation. Its activity is dependent on MBD1 and is heritably maintained through DNA replication by being recruited by CAF-1. SETDB1 is targeted to histone H3 by TRIM28/TIF1B, a factor recruited by KRAB zinc-finger proteins.<ref>PMID:12869583</ref> <ref>PMID:14536086</ref> <ref>PMID:15327775</ref> <ref>PMID:17952062</ref> |
- | [[Category: | + | == References == |
- | [[Category: | + | <references/> |
- | [[Category: | + | __TOC__ |
- | [[Category: | + | </StructureSection> |
- | [[Category: Krojer | + | [[Category: Homo sapiens]] |
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: | + | [[Category: Arrowsmith CH]] |
- | [[Category: | + | [[Category: BRANDAO-NETO J]] |
- | [[Category: Tempel | + | [[Category: Bountra C]] |
+ | [[Category: Collins PM]] | ||
+ | [[Category: DOUANGAMATH A]] | ||
+ | [[Category: Edwards AM]] | ||
+ | [[Category: Harding RJ]] | ||
+ | [[Category: Krojer T]] | ||
+ | [[Category: Mader P]] | ||
+ | [[Category: Santhakumar V]] | ||
+ | [[Category: Schapira M]] | ||
+ | [[Category: Tempel W]] | ||
+ | [[Category: Von Delft F]] |
Current revision
PanDDA analysis group deposition -- Partial occupancy interpretation of PanDDA event map: SETDB1 in complex with FMOPL000074a
|
Categories: Homo sapiens | Large Structures | Arrowsmith CH | BRANDAO-NETO J | Bountra C | Collins PM | DOUANGAMATH A | Edwards AM | Harding RJ | Krojer T | Mader P | Santhakumar V | Schapira M | Tempel W | Von Delft F